White House drops Heidi Overton as FDA chief nominee after GOP senators withhold support

Bill Cassidy cited an abortion policy dispute behind the withdrawal, while the FDA faces uncertainty over its leadership and mifepristone review
Heidi Overton's nomination was withdrawn as the FDA prepared to complete its safety review of the abortion pill mifepristone by March (Getty Images | Tasos Katopodis)
Heidi Overton's nomination was withdrawn as the FDA prepared to complete its safety review of the abortion pill mifepristone by March (Getty Images | Tasos Katopodis)

WASHINGTON, DC: The White House on Tuesday, November 17, withdrew Dr. Heidi Overton's nomination to lead the Food and Drug Administration (FDA), abandoning her confirmation bid just a day before a Senate committee was scheduled to vote on whether to advance her appointment.

The decision followed weeks of resistance and uncertainty among Republican senators over her qualifications, scientific independence and positions on abortion and vaccines. The move leaves the FDA without a permanent commissioner.

White House drops Heidi Overton's FDA nomination after GOP senators raise concerns

A White House official confirmed the decision in an interview with Axios, which first reported the withdrawal. Overton, a preventive medicine physician and White House domestic policy official, was nominated by President Donald Trump in August. She previously served as chief policy officer at the conservative America First Policy Institute and has worked for Trump and organizations aligned with his agenda.

HHS Secretary Robert F Kennedy Jr and Dr Heidi Overton (R) stood in the Oval Office on August 10, 2026, in Washington, DC (Getty Images | Anna Moneymaker)

Overton's nomination faced bipartisan questions during the confirmation process, particularly over whether she would be willing to challenge the administration on scientific and public health matters. Republican Senator Bill Cassidy, chairman of the Senate Health, Education, Labor and Pensions Committee, had also raised concerns about her lack of managerial experience and ability to lead the agency.

Cassidy had questioned Overton's support for Trump's proposal to separate combination vaccines, including the measles, mumps and rubella vaccine, describing that position as "almost disqualifying". During her September confirmation hearing, the Louisiana lawmaker pressed her on whether she would maintain scientific independence from Trump and Health Secretary Robert F Kennedy Jr, a longtime vaccine critic.

HHS Secretary Robert F Kennedy Jr spoke as President Donald Trump and Heidi Overton listened during an executive order signing on vaccines at the White House on August 10, 2026 (AP Photos)

Other Republican senators had also withheld commitments to support her nomination. Senator Susan Collins said last week that she was undecided and needed "to get some answers on various things.” Senator Lisa Murkowski had questioned Overton about political pressure surrounding access to mifepristone and criticized her for not taking a clear position on the issue.

To advance from the 21-member committee, Overton needed the support of at least 11 senators. With Democrats holding 11 seats, she would have needed Republican backing to secure a favorable committee vote and proceed to consideration by the full Senate.

Bill Cassidy links Heidi Overton's withdrawal to abortion policy dispute

Following the nomination withdrawal, Cassidy criticized the administration, suggesting Overton could have secured confirmation if the dispute over abortion policy had not emerged.

"Tonight, the White House abandoned a viable confirmation path for Dr. Overton," Cassidy wrote on X. "My conversations with her convinced me she would follow the science and push back against decisions that put Americans' health at risk."

The senator also shared a longer statement explaining his position and claimed that the final obstacle involved assurances sought by anti-abortion Republican senators.

Heidi Overton's position on abortion and mifepristone

Sen Bill Cassidy (R-LA) attended Dr. Heidi Overton's Senate confirmation hearing on September 24, 2026, at the US Capitol in Washington, DC (Getty Images | Tasos Katopodis)

Overton has praised the Supreme Court's decision to overturn Roe v Wade and advocated strict restrictions on medication abortion.

In a 2023 policy brief for the America First Policy Institute, she called for tighter regulation of mifepristone, criticized federal policies allowing abortion pills to be mailed and argued that abortion "is corrosive to children, women, and society broadly".

GET BREAKING U.S. NEWS & POLITICAL UPDATES
STRAIGHT TO YOUR INBOX.

MORE STORIES

Mary Peltola's win marked Alaska's first Democratic Senate victory since 2008, flipping a state Trump won by 13 points in 2024
2026-11-18T04:44:43.000Z
Elon Musk's remarks followed a rare four-hour FAA nationwide ground stop, triggered by an overload of data on routers
2026-11-18T04:14:57.000Z
Secretary of State Marco Rubio said the Microsoft, FAA and banking disruptions were separate incidents with no indication of foreign interference
2026-11-18T04:06:47.000Z
As the number of outages rise, UK promotes a 72-hour emergency preparedness campaign and Japan urges households to maintain essential supplies amid wider concerns about crisis readiness
2026-11-18T03:20:53.000Z
Former White House press secretary Karoline Leavitt questioned the administration's response as disruptions affected banking, aviation and online services
2026-11-18T02:40:25.000Z
Mullin made the trip aboard a government aircraft while passengers were still facing disruption following the nationwide FAA shutdown
2026-11-17T17:25:22.000Z
Treasury Secretary Scott Bessent reportedly relocated from his Washington-area residence to a military base following threats to his life from Iran
2026-11-17T07:43:00.000Z
JD Vance explained that intelligence assessments can sometimes contradict one another, making it difficult to establish the truth
2026-11-17T07:23:49.000Z
JD Vance said he has yet to decide on a 2028 presidential run, as attention turns to his political future after Republican midterm losses
2026-11-17T06:23:54.000Z
Jensen Huang's exit raised fears that Chinese firms could access Nvidia's advanced AI chips remotely through data centers in Southeast Asia
2026-11-17T03:56:24.000Z